Analysis of Complications After Robot-Assisted Radical Cystectomy Between 2002-2021.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
01 2023
Historique:
received: 03 08 2022
revised: 17 08 2022
accepted: 21 08 2022
pubmed: 15 10 2022
medline: 11 1 2023
entrez: 14 10 2022
Statut: ppublish

Résumé

To identify trends in complications following robot-assisted radical cystectomy (RARC) using a multi-institutional database, the International Robotic Cystectomy Consortium (IRCC). A retrospective review of the IRCC database was performed (2976 patients, 26 institutions from 11 countries). Postoperative complications were categorized as overall or high grade (≥ Clavien Dindo III) and were further categorized based on type/organ site. Descriptive statistics was used to summarize the data. Multivariate analysis (MVA) was used to identify variables associated with overall and high-grade complications.  Cochran-Armitage trend test was used to describe the trend of complications over time. 1777 (60%) patients developed postoperative complications following RARC, 51% of complications occurred within 30 days of RARC, 19% between 30-90 days, and 30% after 90 days. 835 patients (28%) experienced high-grade complications. Infectious complications (25%) were the most prevalent, while bleeding (1%) was the least. The incidence of complications was stable between 2002-2021. Gastrointestinal and neurologic postoperative complications increased significantly (P < .01, for both) between 2005 and 2020 while thromboembolic (P = .03) and wound complications (P < .01) decreased. On MVA, BMI (OR 1.03, 95%CI 1.01-1.05, P < .01), prior abdominal surgery (OR 1.26, 95%CI 1.03-1.56, P = .03), receipt of neobladder (OR 1.52, 95%CI 1.17-1.99, P < .01), positive nodal disease (OR 1.33, 95%CI 1.05-1.70, P = .02), length of inpatient stay (OR 1.04, 95%CI 1.02-1.05, P < .01) and ICU admission (OR 1.67, 95%CI 1.36-2.06, P < .01) were associated with high-grade complications. Overall and high-grade complications after RARC remained stable between 2002-2021. GI and neurologic complications increased, while thromboembolic and wound complications decreased.

Identifiants

pubmed: 36241062
pii: S0090-4295(22)00832-9
doi: 10.1016/j.urology.2022.08.049
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

133-139

Commentaires et corrections

Type : CommentIn

Informations de copyright

Published by Elsevier Inc.

Auteurs

Holly Ann Houenstein (HA)

Roswell Park Comprehensive Cancer Center.

Zhe Jing (Z)

Roswell Park Comprehensive Cancer Center.

Ahmed S Elsayed (AS)

Roswell Park Comprehensive Cancer Center.

Yousuf O Ramahi (YO)

Roswell Park Comprehensive Cancer Center.

Carl Wijburg (C)

Rijnstate Hospital.

Abolfazl Hosseini (A)

Karolinska Institute.

Peter Wiklund (P)

Karolinska Institute.

Eric Kim (E)

Washington University St. Louis.

Jihad Kaouk (J)

Cleveland Clinic.

Prokar Dasgupta (P)

Guy's Hospital.

Mohammed S Khan (MS)

Guy's Hospital.

Andrew A Wagner (AA)

Beth Israel Deaconess Medical Center.

Johar R Syed (JR)

Henry Ford Health System.

James O Peabody (JO)

Henry Ford Health System.

Ketan Badani (K)

Icahn School of Medicine at Mount Sinai Hospital.

Lee Richstone (L)

Arthur Smith Institute for Urology.

Thomas J Maatman (TJ)

Metro Health Hospital.

Derya Balbay (D)

Koç University Hospital.

Juan P Redorta (JP)

Fundacio Puigvert.

Koon Ho Rha (KH)

Yonsei Medical Health Care System.

Morgan Rouprêt (M)

Hôpital Pitié-Salpétrière.

Ahmed Aboumohamed (A)

Montefiore Medical Center.

Ahmed A Hussein (AA)

Roswell Park Comprehensive Cancer Center.

Khurshid A Guru (KA)

Roswell Park Comprehensive Cancer Center. Electronic address: Khurshid.guru@roswellpark.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH